Implementation of a pharmacist-managed heart failure medication titration clinic

被引:47
作者
Martinez, Amanda S. [1 ]
Saef, Jerold [2 ]
Paszczuk, Anna [2 ]
Bhatt-Chugani, Hetal [2 ]
机构
[1] Tampa Gen Hosp, Tampa, FL 33606 USA
[2] Bay Pines Vet Affairs Healthcare Syst, Bay Pines, FL USA
关键词
PRIMARY-CARE; DOUBLE-BLIND; INTERVENTION; ADHERENCE; MORTALITY; OUTCOMES;
D O I
10.2146/ajhp120267
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose. The development, implementation, and initial results of a pharmacist-managed heart failure (HF) medication titration clinic are described. Summary. In a quality-improvement initiative at a Veterans Affairs health care system, clinical pharmacists were incorporated into the hospital system's interprofessional outpatient HF clinic. In addition, a separate pharmacist-Managed HF medication titration clinic was established, in which pharmacists were granted an advanced scope of practice and prescribing privileges, enabling them to initiate and adjust medication dosages under specific protocols jointly established by cardiology and pharmacy staff. Pharmacists involved in the titration clinic tracked patients' daily body weight, vital signs, and volume status using telephone-monitoring technology and via patient interviews. A retrospective chart review comparing achievement of target doses of angiotensin-converting enzyme inhibitor (ACEI, angiotensin-receptor blocker (ARB), and beta-blocker therapies in a group of patients (n = 28) whose dosage titrations were carried out by nurses or physicians prior to implementation of the pharmacist-managed HF medication titration clinic and a group of patients (n = 27) enrolled in the medication titration clinic during its first six months of operation indicated that target ACEI and ARB doses were achieved in a significantly higher percentage of pharmacist-managed titration clinic enrollees (52.9% versus 31%, p = 0.007). Patients enrolled in the pharmacist-managed HF medication titration clinic also had a significantly higher rate of attainment of optimal beta-blocker doses (49% versus 24.7%, p = 0.012). Conclusion. Implementation of a pharmacist-managed HF medication titration clinic increased the percentage of patients achieving optimal ACEI, ARB, and beta-blocker dosages.
引用
收藏
页码:1070 / 1076
页数:7
相关论文
共 23 条
[1]   Evaluation of pharmacist-managed diabetes mellitus under a collaborative drug therapy agreement [J].
Anaya, Jaime P. ;
Rivera, Jose O. ;
Lawson, Ken ;
Garcia, Jose ;
Luna, Jose, Jr. ;
Ortiz, Melchor .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (19) :1841-1845
[2]  
[Anonymous], 2007, PBM MAP CLIN PRACT G
[3]  
CLELAND JGF, 1984, BRIT HEART J, V52, P530
[4]   Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey [J].
Cleland, JGF ;
Cohen-Solal, A ;
Aguilar, JC ;
Dietz, R ;
Eastaugh, J ;
Follath, F ;
Freemantle, N ;
Gavazzi, A ;
van Gilst, WH ;
Hobbs, FDR ;
Korewicki, J ;
Madeira, HC ;
Preda, I ;
Swedberg, K ;
Widimsky, J .
LANCET, 2002, 360 (9346) :1631-1639
[5]   Development of a pharmacist-managed lipid clinic [J].
Cording, MA ;
Engelbrecht-Zadvorny, EB ;
Pettit, BJ ;
Eastham, JH ;
Sandoval, R .
ANNALS OF PHARMACOTHERAPY, 2002, 36 (05) :892-904
[6]   CONTRASTING PERIPHERAL SHORT-TERM AND LONG-TERM EFFECTS OF CONVERTING ENZYME-INHIBITION IN PATIENTS WITH CONGESTIVE HEART-FAILURE - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
DREXLER, H ;
BANHARDT, U ;
MEINERTZ, T ;
WOLLSCHLAGER, H ;
LEHMANN, M ;
JUST, H .
CIRCULATION, 1989, 79 (03) :491-502
[7]   Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team - Results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study [J].
Gattis, WA ;
Hasselblad, V ;
Whellan, DJ ;
O'Connor, CM .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (16) :1939-1945
[8]   Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure -: The metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF) [J].
Hjalmarson, Å ;
Goldstein, S ;
Fagerberg, B ;
Wedel, H ;
Waagstein, F ;
Kjekshus, J ;
Wikstrand, J ;
El Allaf, D ;
Vítovec, J ;
Aldershvile, J ;
Halinen, M ;
Dietz, R ;
Neuhaus, KL ;
Jánosi, A ;
Thorgeirsson, G ;
Dunselman, PHJM ;
Gullestad, L ;
Kuch, J ;
Herlitz, J ;
Rickenbacher, P ;
Ball, S ;
Gottlieb, S ;
Deedwania, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (10) :1295-1302
[9]  
Hunt SA, 2005, CIRCULATION, V112, pE154, DOI [10.1161/CIRCULATIONAHA.105.167586, 10.1161/CIRCULATIONAHA.105.167587]
[10]   Success of a multidisciplinary heart failure clinic for initiation and up-titration of key therapeutic agents [J].
Jain, A ;
Mills, P ;
Nunn, LM ;
Butler, J ;
Luddington, L ;
Ross, V ;
Cliffe, P ;
Timmis, AD .
EUROPEAN JOURNAL OF HEART FAILURE, 2005, 7 (03) :405-410